Timing of adjuvant and neoadjuvant therapy in colorectal cancers

Soley Bayraktar, Ulas Bayraktar, Caio Rocha-Lima

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Surgery remains the only curative therapy for colorectal cancer (CRC); however, several studies have proved that adjuvant chemotherapy improves the curative rate. A growing body of evidence indicates that significant deviations from recommended treatment plans are frequent. Patients may experience delays in the administration of adjuvant chemotherapy that can reduce its survival benefit. To date, few studies have examined factors associated with the timing of adjuvant chemotherapy or have described the effects of delayed therapy on overall survival. In this review, we discuss the extent and predictors of delay in administration of adjuvant chemotherapy as well as the relationship between timing and outcomes in CRC.

Original languageEnglish
Pages (from-to)144-149
Number of pages6
JournalClinical Colorectal Cancer
Volume9
Issue number3
DOIs
StatePublished - Jul 1 2010

Fingerprint

Neoadjuvant Therapy
Adjuvant Chemotherapy
Colorectal Neoplasms
Survival
Therapeutics

Keywords

  • Anastomosis
  • Hepatic artery infusion
  • Portal vein infusion
  • Wound healing

ASJC Scopus subject areas

  • Oncology
  • Gastroenterology

Cite this

Timing of adjuvant and neoadjuvant therapy in colorectal cancers. / Bayraktar, Soley; Bayraktar, Ulas; Rocha-Lima, Caio.

In: Clinical Colorectal Cancer, Vol. 9, No. 3, 01.07.2010, p. 144-149.

Research output: Contribution to journalArticle

Bayraktar, Soley ; Bayraktar, Ulas ; Rocha-Lima, Caio. / Timing of adjuvant and neoadjuvant therapy in colorectal cancers. In: Clinical Colorectal Cancer. 2010 ; Vol. 9, No. 3. pp. 144-149.
@article{63a3e654f4fd410bb359ff3ff0220a91,
title = "Timing of adjuvant and neoadjuvant therapy in colorectal cancers",
abstract = "Surgery remains the only curative therapy for colorectal cancer (CRC); however, several studies have proved that adjuvant chemotherapy improves the curative rate. A growing body of evidence indicates that significant deviations from recommended treatment plans are frequent. Patients may experience delays in the administration of adjuvant chemotherapy that can reduce its survival benefit. To date, few studies have examined factors associated with the timing of adjuvant chemotherapy or have described the effects of delayed therapy on overall survival. In this review, we discuss the extent and predictors of delay in administration of adjuvant chemotherapy as well as the relationship between timing and outcomes in CRC.",
keywords = "Anastomosis, Hepatic artery infusion, Portal vein infusion, Wound healing",
author = "Soley Bayraktar and Ulas Bayraktar and Caio Rocha-Lima",
year = "2010",
month = "7",
day = "1",
doi = "10.3816/CCC.2010.n.019",
language = "English",
volume = "9",
pages = "144--149",
journal = "Clinical Colorectal Cancer",
issn = "1533-0028",
publisher = "Elsevier",
number = "3",

}

TY - JOUR

T1 - Timing of adjuvant and neoadjuvant therapy in colorectal cancers

AU - Bayraktar, Soley

AU - Bayraktar, Ulas

AU - Rocha-Lima, Caio

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Surgery remains the only curative therapy for colorectal cancer (CRC); however, several studies have proved that adjuvant chemotherapy improves the curative rate. A growing body of evidence indicates that significant deviations from recommended treatment plans are frequent. Patients may experience delays in the administration of adjuvant chemotherapy that can reduce its survival benefit. To date, few studies have examined factors associated with the timing of adjuvant chemotherapy or have described the effects of delayed therapy on overall survival. In this review, we discuss the extent and predictors of delay in administration of adjuvant chemotherapy as well as the relationship between timing and outcomes in CRC.

AB - Surgery remains the only curative therapy for colorectal cancer (CRC); however, several studies have proved that adjuvant chemotherapy improves the curative rate. A growing body of evidence indicates that significant deviations from recommended treatment plans are frequent. Patients may experience delays in the administration of adjuvant chemotherapy that can reduce its survival benefit. To date, few studies have examined factors associated with the timing of adjuvant chemotherapy or have described the effects of delayed therapy on overall survival. In this review, we discuss the extent and predictors of delay in administration of adjuvant chemotherapy as well as the relationship between timing and outcomes in CRC.

KW - Anastomosis

KW - Hepatic artery infusion

KW - Portal vein infusion

KW - Wound healing

UR - http://www.scopus.com/inward/record.url?scp=77955005391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955005391&partnerID=8YFLogxK

U2 - 10.3816/CCC.2010.n.019

DO - 10.3816/CCC.2010.n.019

M3 - Article

VL - 9

SP - 144

EP - 149

JO - Clinical Colorectal Cancer

JF - Clinical Colorectal Cancer

SN - 1533-0028

IS - 3

ER -